Mubadala Investment Company, the sovereign wealth fund of Abu Dhabi, has finalized a significant investment in UCB Pharma's assets in China. This strategic move underscores Mubadala's growing commitment to the global healthcare sector and its expanding presence in the Chinese market. The deal involves Mubadala acquiring a substantial stake in UCB

By Nichola Saminather | SINGAPORE SINGAPORE Asian stocks retreated on Thursday, taking their cues from a subdued session on Wall Street,
By Se Young Lee and Anjali Athavaley | SEOUL/NEW YORK - SEOUL/NEW YORK - Samsung Electronics Co Ltd (005930.KS) unveiled its
By Rodrigo Campos and Megan Davies | NEW YORK NEW YORK U.S. stock index futures rose sharply on Sunday on relief